Agenus (AGEN) Return on Capital Employed Growth (5y) (2016 - 2026)
Agenus (AGEN) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn |
| 10 | Agenus | 230.87 Mn | 195.87 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,265.00 |
| Dec 31, 2025 | 16,891.00 |
| Sep 30, 2025 | 20,905.00 |
| Jun 30, 2025 | 23,911.00 |
| Mar 31, 2025 | -173,909.00 |
| Dec 31, 2024 | -93,404.00 |
| Sep 30, 2024 | 11,854.00 |
| Jun 30, 2024 | -289,657.00 |
| Mar 31, 2024 | -40,714.00 |
| Dec 31, 2023 | -4,252.00 |
| Sep 30, 2023 | 2,444.00 |
| Jun 30, 2023 | 9,708.00 |
| Mar 31, 2023 | 3,746.00 |
| Dec 31, 2022 | 7,582.00 |
| Sep 30, 2022 | 2,099.00 |
| Jun 30, 2022 | 7,041.00 |
| Mar 31, 2022 | 6,249.00 |
| Dec 31, 2021 | 9,467.00 |
| Sep 30, 2021 | 10,548.00 |
| Jun 30, 2021 | -32,025.00 |